Integration of new or experimental treatment options and new approaches to clinical trials
Ann Oncol
.
2005:16 Suppl 8:viii30-viii35.
doi: 10.1093/annonc/mdi964.
Authors
M Quinn
1
,
J Pfisterer
,
E Avall-Lundqvist
,
M Bookman
,
D Bowtell
,
A Casado
,
A Cervantes
,
S Grenman
,
P Harper
,
A Oza
,
S Pecorelli
,
E Pujade-Lauraine
,
E Trimble
,
P Vasey
,
U Wagner
;
ANZGOG
;
AGO-OVAR
;
NSGO
;
GOG
;
EORTC
;
GEICO
;
MRC/NCRI
;
NCIC-CTG
;
IGCS
;
GINECO
;
NCI-US
;
SGCTG
Affiliation
1
Oncology Unit, Royal Women's Hospital, Carlton, Australia. maquinn@unimelb.edu.au
PMID:
16239234
DOI:
10.1093/annonc/mdi964
No abstract available
Publication types
Consensus Development Conference
Research Support, Non-U.S. Gov't
MeSH terms
Clinical Trials as Topic / methods
Combined Modality Therapy
Female
Humans
Ovarian Neoplasms / therapy*
Research Design